{"transactions":[{"id":1213597,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":16644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Represents the date upon which the first 25% of the option granted vests. 1/48th of the total granted option vests and become exercisable on each monthly anniversary thereafter."}],"balance_after":16644,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":16644},"source":{"system":"sec-edgar","filing":"0000950170-25-037516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037516/ownership.xml","form_type":"4"}},{"id":1213596,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Performance Stock Units","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":false,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-25-037516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037516/ownership.xml","form_type":"4"}},{"id":1213595,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":8276,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. 25% of the shares of common stock underlying each RSU will vest on the first anniversary of the grant date, and additional 25% will vest on each anniversary of the Grant Date thereafter, such that the RSUs will be fully vested on the fourth anniversary of the grant date."}],"balance_after":38202,"source":{"system":"sec-edgar","filing":"0000950170-25-037516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037516/ownership.xml","form_type":"4"}},{"id":1213594,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":2737,"price":100.13,"value":274055.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 7, 2022."}],"balance_after":29926,"source":{"system":"sec-edgar","filing":"0000950170-25-037516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037516/ownership.xml","form_type":"4"}},{"id":1213593,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":996,"price":100.13,"value":99729.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 7, 2022."}],"balance_after":32663,"source":{"system":"sec-edgar","filing":"0000950170-25-037516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037516/ownership.xml","form_type":"4"}},{"id":1213592,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-12T00:00:07.000Z","date":"2025-03-07","kind":"exercise","planned":false,"acquired":true,"shares":5500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 7, 2022. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":33659,"source":{"system":"sec-edgar","filing":"0000950170-25-037516","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037516/ownership.xml","form_type":"4"}},{"id":1216321,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Performance Stock Units","published_at":"2025-03-11T00:00:05.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-036692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036692/ownership.xml","form_type":"4"}},{"id":1216320,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:05.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":8613,"price":103.7,"value":893168.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 6, 2023."}],"balance_after":28159,"source":{"system":"sec-edgar","filing":"0000950170-25-036692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036692/ownership.xml","form_type":"4"}},{"id":1216319,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:05.000Z","date":"2025-03-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":549,"price":103.7,"value":56931.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 6, 2023."}],"balance_after":36772,"source":{"system":"sec-edgar","filing":"0000950170-25-036692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036692/ownership.xml","form_type":"4"}},{"id":1216318,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-11T00:00:05.000Z","date":"2025-03-06","kind":"exercise","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 6, 2023. The number of shares earned was based on the Compensation Committee's determination of the Company's achievement of the milestones under the terms of the PSU."}],"balance_after":37321,"source":{"system":"sec-edgar","filing":"0000950170-25-036692","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025036692/ownership.xml","form_type":"4"}},{"id":1220719,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-07T01:00:06.000Z","date":"2025-03-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":1685,"price":101.34,"value":170757.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 3, 2021."}],"balance_after":19821,"source":{"system":"sec-edgar","filing":"0000950170-25-035004","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025035004/ownership.xml","form_type":"4"}},{"id":1232459,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:00:09.000Z","date":"2025-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":711,"price":103.77,"value":73780.47,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on March 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount of Securities Beneficially Owned includes 194 shares purchased under the Company's registered Employee Stock Purchase Plan on February 28, 2025."}],"balance_after":21506,"source":{"system":"sec-edgar","filing":"0000950170-25-032762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025032762/ownership.xml","form_type":"4"}},{"id":1270400,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Performance Restricted Stock Units","published_at":"2025-02-14T01:00:04.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":3500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the total number of shares earned under a PSU award granted to the Reporting Person on March 6, 2023. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of the prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 6, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":17500,"derivative":{"underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0000950170-25-020192","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025020192/ownership.xml","form_type":"4"}},{"id":1470010,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:05.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":false,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077520/ownership.xml","form_type":"4"}},{"id":1470009,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:05.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":6250,"derivative":{"underlying":"Common Stock","underlying_shares":6250},"source":{"system":"sec-edgar","filing":"0000950170-24-077520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077520/ownership.xml","form_type":"4"}},{"id":1470008,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Performance Stock Units","published_at":"2024-06-26T00:00:05.000Z","date":"2024-06-21","kind":"grant","planned":false,"acquired":true,"shares":5500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date."}],"balance_after":5500,"derivative":{"underlying":"Common Stock","underlying_shares":5500},"source":{"system":"sec-edgar","filing":"0000950170-24-077520","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077520/ownership.xml","form_type":"4"}},{"id":1470007,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:05.000Z","date":"2024-06-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":2352,"price":164.64,"value":387233.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024."}],"balance_after":22023,"source":{"system":"sec-edgar","filing":"0000950170-24-077520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077520/ownership.xml","form_type":"4"}},{"id":1470006,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2024-06-26T00:00:05.000Z","date":"2024-06-21","kind":"exercise","planned":false,"acquired":true,"shares":6250,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the number of shares earned and vested under a performance stock unit (\"PSU\") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU."}],"balance_after":24375,"source":{"system":"sec-edgar","filing":"0000950170-24-077520","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024077520/ownership.xml","form_type":"4"}},{"id":1526864,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":82175,"kind":"person","name":"Murray Dallan","position":1,"cik":"0002022303","reported_name":"Murray Dallan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Customer Officer"}}],"security":"Common Stock","published_at":"2024-05-07T00:09:06.000Z","date":"2024-05-02","kind":"sale","planned":true,"acquired":false,"shares":3635,"price":140,"value":508900.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 15, 2024."}],"balance_after":18125,"source":{"system":"sec-edgar","filing":"0000950170-24-053837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024053837/ownership.xml","form_type":"4"}}]}